WallStreetZenWallStreetZen

NYSE: ZTS
Zoetis Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ZTS

Based on 5 analysts offering 12 month price targets for Zoetis Inc

Min Forecast
$165.00+12.36%
Avg Forecast
$213.40+45.32%
Max Forecast
$244.00+66.16%

Should I buy or sell ZTS stock?

Based on 5 analysts offering ratings for Zoetis Inc.

Strong Buy
Strong Buy
4 analysts 80%
Buy
1 analysts 20%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ZTS's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ZTS as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their ZTS stock forecasts and price targets.

ZTS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-14
lockedlocked$00.00+00.00%2025-02-27
lockedlocked$00.00+00.00%2025-02-14
lockedlocked$00.00+00.00%2025-02-14
lockedlocked$00.00+00.00%2024-12-09
Leerink Partners
Bottom 36%
36
BuyInitiates Coverage On$215.00+46.41%2024-12-02

1 of 1

Forecast return on equity

Is ZTS forecast to generate an efficient return?

Company
72.33%
Industry
44.61%
Market
81.87%
ZTS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ZTS forecast to generate an efficient return on assets?

Company
24.23%
Industry
15.28%
ZTS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ZTS earnings per share forecast

What is ZTS's earnings per share in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
$6.08+11.09%
Avg 2 year Forecast
$6.65+21.63%
Avg 3 year Forecast
$7.19+31.48%
ZTS's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

ZTS revenue forecast

What is ZTS's revenue in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$9.3B+0.6%
Avg 2 year Forecast
$9.9B+6.79%
Avg 3 year Forecast
$10.4B+12.71%
ZTS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ZTS earnings growth forecast

How is ZTS forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
9.6%
Industry
23.44%
Market
18.17%
ZTS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
ZTS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
ZTS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

ZTS revenue growth forecast

How is ZTS forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
4.09%
Industry
4.41%
Market
10.37%
ZTS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ZTS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ZTS vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
ZTS$146.85$213.40+45.32%Strong Buy
TAK$14.93N/AN/A
HLN$10.19N/AN/A
TEVA$13.31$25.75+93.46%Strong Buy
RDY$13.67N/AN/A
View Top Pharmaceutical Stocks

Zoetis Stock Forecast FAQ

Is Zoetis Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NYSE: ZTS) stock is to Strong Buy ZTS stock.

Out of 5 analysts, 4 (80%) are recommending ZTS as a Strong Buy, 1 (20%) are recommending ZTS as a Buy, 0 (0%) are recommending ZTS as a Hold, 0 (0%) are recommending ZTS as a Sell, and 0 (0%) are recommending ZTS as a Strong Sell.

If you're new to stock investing, here's how to buy Zoetis stock.

What is ZTS's earnings growth forecast for 2025-2027?

(NYSE: ZTS) Zoetis's forecast annual earnings growth rate of 9.6% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 23.44%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.17%.

Zoetis's earnings in 2025 is $2,486,000,000.On average, 11 Wall Street analysts forecast ZTS's earnings for 2025 to be $2,720,962,804, with the lowest ZTS earnings forecast at $2,709,141,098, and the highest ZTS earnings forecast at $2,753,920,290. On average, 10 Wall Street analysts forecast ZTS's earnings for 2026 to be $2,979,159,624, with the lowest ZTS earnings forecast at $2,856,912,430, and the highest ZTS earnings forecast at $3,053,940,874.

In 2027, ZTS is forecast to generate $3,220,385,129 in earnings, with the lowest earnings forecast at $3,089,764,227 and the highest earnings forecast at $3,376,351,054.

What is ZTS's revenue growth forecast for 2025-2027?

(NYSE: ZTS) Zoetis's forecast annual revenue growth rate of 4.09% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.41%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.37%.

Zoetis's revenue in 2025 is $9,256,000,000.On average, 8 Wall Street analysts forecast ZTS's revenue for 2025 to be $4,169,605,031,515, with the lowest ZTS revenue forecast at $4,146,105,359,503, and the highest ZTS revenue forecast at $4,197,153,638,041. On average, 8 Wall Street analysts forecast ZTS's revenue for 2026 to be $4,426,019,191,236, with the lowest ZTS revenue forecast at $4,359,702,103,912, and the highest ZTS revenue forecast at $4,482,110,054,551.

In 2027, ZTS is forecast to generate $4,671,574,396,969 in revenue, with the lowest revenue forecast at $4,513,742,523,360 and the highest revenue forecast at $4,830,606,352,916.

What is ZTS's forecast return on assets (ROA) for 2025-2028?

(NYSE: ZTS) forecast ROA is 24.23%, which is higher than the forecast US Drug Manufacturers - Specialty & Generic industry average of 15.28%.

What is ZTS's Price Target?

According to 5 Wall Street analysts that have issued a 1 year ZTS price target, the average ZTS price target is $213.40, with the highest ZTS stock price forecast at $244.00 and the lowest ZTS stock price forecast at $165.00.

On average, Wall Street analysts predict that Zoetis's share price could reach $213.40 by Apr 14, 2026. The average Zoetis stock price prediction forecasts a potential upside of 45.32% from the current ZTS share price of $146.85.

What is ZTS's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSE: ZTS) Zoetis's current Earnings Per Share (EPS) is $5.47. On average, analysts forecast that ZTS's EPS will be $6.08 for 2025, with the lowest EPS forecast at $6.05, and the highest EPS forecast at $6.15. On average, analysts forecast that ZTS's EPS will be $6.65 for 2026, with the lowest EPS forecast at $6.38, and the highest EPS forecast at $6.82. In 2027, ZTS's EPS is forecast to hit $7.19 (min: $6.90, max: $7.54).

What is ZTS's forecast return on equity (ROE) for 2025-2028?

(NYSE: ZTS) forecast ROE is 72.33%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.